Intellectual Disability
|
0.100 |
Biomarker
|
group |
BEFREE |
DYRK1A-related intellectual disability: a syndrome associated with congenital anomalies of the kidney and urinary tract.
|
31263215 |
2019 |
Intellectual Disability
|
0.100 |
GeneticVariation
|
group |
BEFREE |
Autosomal dominant mental retardation-7 (MRD7) is a rare anomaly, characterized by severe intellectual disability, feeding difficulties, behavior abnormalities, and distinctive facial features, including microcephaly, deep-set eyes, large simple ears, and a pointed or bulbous nasal tip.
|
31803247 |
2019 |
Intellectual Disability
|
0.100 |
Biomarker
|
group |
BEFREE |
DYRK1A contributes to intellectual disability and the early onset of Alzheimer's disease in DS patients.
|
26803494 |
2017 |
Intellectual Disability
|
0.100 |
AlteredExpression
|
group |
BEFREE |
Furthermore, Dyrk1a is upregulated in postmortem human brains, and high levels of Dyrk1a are associated with mental retardation.
|
28779511 |
2017 |
Intellectual Disability
|
0.100 |
GeneticVariation
|
group |
BEFREE |
More recently, point mutations in DYRK1A have been shown to be responsible for a recognizable syndrome characterized by microcephaly, developmental delay and intellectual disability (ID) as well as characteristic facial features.
|
26922654 |
2016 |
Intellectual Disability
|
0.100 |
Biomarker
|
group |
BEFREE |
The rise of next generation sequencing (NGS) and array-CGH (aCGH) in diagnostic settings for the evaluation of patients with ID allowed the identification of 17 patients carrying heterozygous genetic aberrations involving DYRK1A to date.
|
25641759 |
2015 |
Intellectual Disability
|
0.100 |
Biomarker
|
group |
BEFREE |
In the present study, we report 10 unrelated individuals with DYRK1A-associated intellectual disability (ID) who display a recurrent pattern of clinical manifestations including primary or acquired microcephaly, ID ranging from mild to severe, speech delay or absence, seizures, autism, motor delay, deep-set eyes, poor feeding and poor weight gain.
|
25920557 |
2015 |
Intellectual Disability
|
0.100 |
Biomarker
|
group |
BEFREE |
It has been proposed that DYRK1A plays a prominent role in several biological functions, leading to mental retardation in DS patients.
|
23124096 |
2013 |
Intellectual Disability
|
0.100 |
Biomarker
|
group |
BEFREE |
While not genome-wide significant, the gene with the strongest association (p-value = 8.7×10(-5)) was DYRK1A, a gene previously related to abnormal brain development and mental retardation.
|
23077488 |
2012 |
Intellectual Disability
|
0.100 |
GeneticVariation
|
group |
BEFREE |
The triplication of the DYRK1A gene encoding proline-directed serine/threonine kinase and located in the critical region of Down syndrome (DS) has been implicated in cognitive deficits and intellectual disability of individuals with DS.
|
23147510 |
2012 |
Intellectual Disability
|
0.100 |
GeneticVariation
|
group |
BEFREE |
Because four patients previously reported with intragenic DYRK1A rearrangements or 21q22 microdeletions including only DYRK1A presented with overlapping phenotypes, we hypothesised that DYRK1A mutations could be responsible for syndromic ID with severe microcephaly and epilepsy.
|
23099646 |
2012 |
Intellectual Disability
|
0.100 |
AlteredExpression
|
group |
BEFREE |
The identification of hundreds of genes deregulated by DYRK1A overexpression and numerous cytosolic, cytoskeletal and nuclear proteins, including transcription factors, phosphorylated by DYRK1A, indicates that DYRK1A overexpression is central for the deregulation of multiple pathways in the developing and aging DS brain, with structural and functional alterations including mental retardation and dementia.
|
21156028 |
2011 |
Intellectual Disability
|
0.100 |
GeneticVariation
|
group |
BEFREE |
The dual-specificity tyrosine(Y)-phosphorylation-regulated kinase 1A (Dyrk1A) gene is located on human chromosome 21 and encodes a proline-directed protein kinase that might be responsible for mental retardation and early onset of Alzheimer's disease (AD) in Down syndrome (DS) patients.
|
20456003 |
2010 |
Intellectual Disability
|
0.100 |
AlteredExpression
|
group |
BEFREE |
Trisomy 21-linked Dyrk1A (dual-specificity tyrosine phosphorylation-regulated kinase 1A) overexpression is implicated in pathogenic mechanisms underlying mental retardation in Down syndrome (DS).
|
21135538 |
2010 |
Intellectual Disability
|
0.100 |
Biomarker
|
group |
BEFREE |
DYRK1A is a serine/threonine kinase that has been linked to mental retardation associated with Down syndrome.
|
19801542 |
2009 |
Intellectual Disability
|
0.100 |
AlteredExpression
|
group |
BEFREE |
It also implies that overexpression of DYRK1A in DS may be potentially relevant to MR status of these individuals during their entire life span.
|
17145134 |
2007 |
Intellectual Disability
|
0.100 |
Biomarker
|
group |
BEFREE |
These alterations are comparable with those found in the partial trisomy chromosome 16 murine models of DS and suggest a causative role of DYRK1A in mental retardation and in motor anomalies of DS.
|
11555628 |
2001 |
Intellectual Disability
|
0.100 |
AlteredExpression
|
group |
BEFREE |
Altered expression of the human MNB gene may be involved in the pathogenesis of certain phenotypes of Down syndrome, including mental retardation.
|
9048932 |
1997 |